Adding rituximab to chemotherapy for diffuse large B-cell lymphoma patients in Indonesia: a cost utility and budget impact analysis

• Główni autorzy: Septiara Putri (Autor), Ery Setiawan (Autor), Siti Rizny F. Saldi (Autor), Levina Chandra Khoe (Autor), Euis Ratna Sari (Autor), Amila Megraini (Autor), Mardiati Nadjib (Autor), Sudigdo Sastroasmoro (Autor), Armansyah Armansyah (Autor)
• Format: Książka
• Wydane: BMC, 2022-04-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Abstract Background Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) has been used to treat patients with diffuse large B-cell lymphoma (DLBCL) under National Health Insurance (NHI) scheme in Indonesia. This study aims to estimate its cost-effectiveness and budget i...